Pharma

Your Article Summary

See Latest Articles

Active Biotechs Prostate Cancer Project TASQ Featured in British Journal of Cancer
Active Biotech, 09/28/09

British Journal of Cancer releases an article covering Active Biotech's prostate cancer project TASQ, where TASQ was studied as a single agent in patients with castration–resistant prostate cancer. Two open–label phase I clinical trials in patients with castration–resistant prostate cancer were conducted to evaluate the safety and tolerability of TASQ, with additional pharmacokinetic and efficacy assessments.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

 See all of Research & Development